Factors associated with postpartum loss to follow-up and detectable viremia after delivery among pregnant women living with HIV

Emily H. Adhikari, Casey S. Yule, Scott W. Roberts, Vanessa L. Rogers, Jeanne Sheffield, Mary Ann Kelly, Donald D. McIntire, Arti Barnes

Research output: Contribution to journalArticle

Abstract

Pregnant women living with HIV are at risk for loss to follow-up and viral rebound after delivery. We conducted a retrospective cohort study of women with HIV who delivered at Parkland Hospital, Dallas, to identify factors associated with postpartum loss to HIV care 1 year after delivery. Logistic regression was used to identify factors predicting loss to follow-up. For a subset of women, we compared odds of viremia detectable at delivery and postpartum among women with higher versus lower pill burden regimens. We included 604 women with HIV who delivered between 2005 and 2015. Three hundred ninety-one (65%) women completed at least one visit with an HIV provider within 1 year of delivery. The follow-up rate among black, non-Hispanic women was 65%; 57% for white, non-Hispanic women; and 78% for Hispanic women. Women without follow-up presented for prenatal care later (17 vs. 11 weeks, p < 0.001), and were less likely to be on antiretroviral therapy at initial prenatal visit (29% vs. 49%, p < 0.001). Factors predicting loss to follow-up in multivariate analysis included low-level viremia at delivery [adjusted odds ratio (aOR) = 2.85, 95% confidence interval (CI) = 1.73-4.71] and failure to return for a postpartum visit (aOR = 3.19, 95% CI = 2.07-4.94). High antiretroviral pill burden (≥6 pills daily) was associated with viremia (>1000 copies/mL) at the first prenatal visit (OR = 8.7, 95% CI = 4.6-16.6) through 1 year postpartum (OR = 2.3, 95% CI = 1.2-4.4). Viremia at delivery, failure to return for a postpartum visit, and high pill burden during pregnancy are predictors of postpartum loss to HIV care.

Original languageEnglish (US)
Pages (from-to)14-20
Number of pages7
JournalAIDS Patient Care and STDs
Volume33
Issue number1
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Fingerprint

Viremia
Postpartum Period
Pregnant Women
HIV
Prenatal Care
Hispanic Americans
HIV-1
Cohort Studies
Retrospective Studies
Logistic Models
Pregnancy

Keywords

  • HIV
  • pill burden
  • postpartum follow-up
  • pregnancy

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Factors associated with postpartum loss to follow-up and detectable viremia after delivery among pregnant women living with HIV. / Adhikari, Emily H.; Yule, Casey S.; Roberts, Scott W.; Rogers, Vanessa L.; Sheffield, Jeanne; Kelly, Mary Ann; McIntire, Donald D.; Barnes, Arti.

In: AIDS Patient Care and STDs, Vol. 33, No. 1, 01.01.2019, p. 14-20.

Research output: Contribution to journalArticle

Adhikari, Emily H. ; Yule, Casey S. ; Roberts, Scott W. ; Rogers, Vanessa L. ; Sheffield, Jeanne ; Kelly, Mary Ann ; McIntire, Donald D. ; Barnes, Arti. / Factors associated with postpartum loss to follow-up and detectable viremia after delivery among pregnant women living with HIV. In: AIDS Patient Care and STDs. 2019 ; Vol. 33, No. 1. pp. 14-20.
@article{9d703f4ca06e4d9180c47ea47cbe2413,
title = "Factors associated with postpartum loss to follow-up and detectable viremia after delivery among pregnant women living with HIV",
abstract = "Pregnant women living with HIV are at risk for loss to follow-up and viral rebound after delivery. We conducted a retrospective cohort study of women with HIV who delivered at Parkland Hospital, Dallas, to identify factors associated with postpartum loss to HIV care 1 year after delivery. Logistic regression was used to identify factors predicting loss to follow-up. For a subset of women, we compared odds of viremia detectable at delivery and postpartum among women with higher versus lower pill burden regimens. We included 604 women with HIV who delivered between 2005 and 2015. Three hundred ninety-one (65{\%}) women completed at least one visit with an HIV provider within 1 year of delivery. The follow-up rate among black, non-Hispanic women was 65{\%}; 57{\%} for white, non-Hispanic women; and 78{\%} for Hispanic women. Women without follow-up presented for prenatal care later (17 vs. 11 weeks, p < 0.001), and were less likely to be on antiretroviral therapy at initial prenatal visit (29{\%} vs. 49{\%}, p < 0.001). Factors predicting loss to follow-up in multivariate analysis included low-level viremia at delivery [adjusted odds ratio (aOR) = 2.85, 95{\%} confidence interval (CI) = 1.73-4.71] and failure to return for a postpartum visit (aOR = 3.19, 95{\%} CI = 2.07-4.94). High antiretroviral pill burden (≥6 pills daily) was associated with viremia (>1000 copies/mL) at the first prenatal visit (OR = 8.7, 95{\%} CI = 4.6-16.6) through 1 year postpartum (OR = 2.3, 95{\%} CI = 1.2-4.4). Viremia at delivery, failure to return for a postpartum visit, and high pill burden during pregnancy are predictors of postpartum loss to HIV care.",
keywords = "HIV, pill burden, postpartum follow-up, pregnancy",
author = "Adhikari, {Emily H.} and Yule, {Casey S.} and Roberts, {Scott W.} and Rogers, {Vanessa L.} and Jeanne Sheffield and Kelly, {Mary Ann} and McIntire, {Donald D.} and Arti Barnes",
year = "2019",
month = "1",
day = "1",
doi = "10.1089/apc.2018.0117",
language = "English (US)",
volume = "33",
pages = "14--20",
journal = "AIDS Patient Care and STDs",
issn = "1087-2914",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Factors associated with postpartum loss to follow-up and detectable viremia after delivery among pregnant women living with HIV

AU - Adhikari, Emily H.

AU - Yule, Casey S.

AU - Roberts, Scott W.

AU - Rogers, Vanessa L.

AU - Sheffield, Jeanne

AU - Kelly, Mary Ann

AU - McIntire, Donald D.

AU - Barnes, Arti

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Pregnant women living with HIV are at risk for loss to follow-up and viral rebound after delivery. We conducted a retrospective cohort study of women with HIV who delivered at Parkland Hospital, Dallas, to identify factors associated with postpartum loss to HIV care 1 year after delivery. Logistic regression was used to identify factors predicting loss to follow-up. For a subset of women, we compared odds of viremia detectable at delivery and postpartum among women with higher versus lower pill burden regimens. We included 604 women with HIV who delivered between 2005 and 2015. Three hundred ninety-one (65%) women completed at least one visit with an HIV provider within 1 year of delivery. The follow-up rate among black, non-Hispanic women was 65%; 57% for white, non-Hispanic women; and 78% for Hispanic women. Women without follow-up presented for prenatal care later (17 vs. 11 weeks, p < 0.001), and were less likely to be on antiretroviral therapy at initial prenatal visit (29% vs. 49%, p < 0.001). Factors predicting loss to follow-up in multivariate analysis included low-level viremia at delivery [adjusted odds ratio (aOR) = 2.85, 95% confidence interval (CI) = 1.73-4.71] and failure to return for a postpartum visit (aOR = 3.19, 95% CI = 2.07-4.94). High antiretroviral pill burden (≥6 pills daily) was associated with viremia (>1000 copies/mL) at the first prenatal visit (OR = 8.7, 95% CI = 4.6-16.6) through 1 year postpartum (OR = 2.3, 95% CI = 1.2-4.4). Viremia at delivery, failure to return for a postpartum visit, and high pill burden during pregnancy are predictors of postpartum loss to HIV care.

AB - Pregnant women living with HIV are at risk for loss to follow-up and viral rebound after delivery. We conducted a retrospective cohort study of women with HIV who delivered at Parkland Hospital, Dallas, to identify factors associated with postpartum loss to HIV care 1 year after delivery. Logistic regression was used to identify factors predicting loss to follow-up. For a subset of women, we compared odds of viremia detectable at delivery and postpartum among women with higher versus lower pill burden regimens. We included 604 women with HIV who delivered between 2005 and 2015. Three hundred ninety-one (65%) women completed at least one visit with an HIV provider within 1 year of delivery. The follow-up rate among black, non-Hispanic women was 65%; 57% for white, non-Hispanic women; and 78% for Hispanic women. Women without follow-up presented for prenatal care later (17 vs. 11 weeks, p < 0.001), and were less likely to be on antiretroviral therapy at initial prenatal visit (29% vs. 49%, p < 0.001). Factors predicting loss to follow-up in multivariate analysis included low-level viremia at delivery [adjusted odds ratio (aOR) = 2.85, 95% confidence interval (CI) = 1.73-4.71] and failure to return for a postpartum visit (aOR = 3.19, 95% CI = 2.07-4.94). High antiretroviral pill burden (≥6 pills daily) was associated with viremia (>1000 copies/mL) at the first prenatal visit (OR = 8.7, 95% CI = 4.6-16.6) through 1 year postpartum (OR = 2.3, 95% CI = 1.2-4.4). Viremia at delivery, failure to return for a postpartum visit, and high pill burden during pregnancy are predictors of postpartum loss to HIV care.

KW - HIV

KW - pill burden

KW - postpartum follow-up

KW - pregnancy

UR - http://www.scopus.com/inward/record.url?scp=85059390543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059390543&partnerID=8YFLogxK

U2 - 10.1089/apc.2018.0117

DO - 10.1089/apc.2018.0117

M3 - Article

VL - 33

SP - 14

EP - 20

JO - AIDS Patient Care and STDs

JF - AIDS Patient Care and STDs

SN - 1087-2914

IS - 1

ER -